The research behind Revayo Prime.

Most supplement brands say "clinically proven" without showing the work. This page is the work. What the peer-reviewed research has actually investigated about hydrolysed collagen peptides in active men — for joint comfort, ankle and connective tissue stability, muscle adaptation, and recovery — and what it doesn't yet show. References are linked to PubMed at the bottom of the page.

Collagen is the most abundant structural protein in the human body. Production by the body declines gradually from the mid-twenties onwards, and the cumulative effect on joints, tendons, ligaments and skeletal muscle becomes increasingly noticeable through the thirties and forties.

Hydrolysed collagen peptides — collagen broken down enzymatically into smaller, more readily absorbed peptide chains — have been investigated in peer-reviewed clinical research for more than two decades. For active men specifically, the most relevant published evidence sits in four areas: activity-related joint discomfort, functional connective tissue stability (ankles, tendons, ligaments), muscle adaptation alongside resistance training, and recovery from exercise-induced muscle damage.

Across the published literature, daily doses studied have typically ranged from 5g to 15g, taken consistently over 12 to 24 weeks, with outcomes measured by validated subjective scales (e.g. Visual Analogue Scale for pain), objective biophysical measurements (e.g. arthrometer readings for joint stability), and laboratory analysis (e.g. muscle biopsy proteomics, blood markers for muscle damage).

This is the area with the strongest published evidence relevant to the Revayo customer. Two large randomised, placebo-controlled trials are particularly worth examining.

Both studies used populations broadly comparable to Revayo's typical customer: physically active adults experiencing activity-related joint discomfort, without any diagnosed joint disease. Both used doses (5g and 10g) within the range Revayo Prime supplies (14.77g per serving). Both reported statistically significant outcomes versus placebo over study periods of 12 to 24 weeks.

Joint comfort is one outcome. Functional connective tissue stability — the structural integrity of the ligaments and tendons that hold joints together — is another, particularly relevant for men with histories of sport-related injuries that have left recurring instability.

This is one of the few studies in the published literature to demonstrate effects extending to re-injury rate in a follow-up period, rather than just symptom outcomes during the intervention. For men with histories of ankle, knee or shoulder instability from previous sport, the findings are directly relevant.

Collagen peptides are not a substitute for whey protein or other complete protein sources when the goal is muscle protein synthesis — collagen is an incomplete protein and lower in leucine. But research has investigated whether specific collagen peptides, taken alongside resistance training, contribute additional benefits to body composition and muscle adaptation.

The practical relevance for men over thirty doing meaningful resistance training: alongside the joint and connective tissue research, there's a separate body of evidence suggesting collagen peptides taken post-training may contribute to muscle adaptation beyond what training alone delivers.

What the research does consistently suggest is that hydrolysed collagen peptides, taken at clinically meaningful doses (5g or more daily) and sustained over a period of 8 to 24 weeks, can offer measurable support for joint comfort, functional connective tissue stability, and muscle adaptation in active populations. The effect sizes are typically modest rather than dramatic. The most reliable signal comes from consistent daily intake sustained over months, not weeks.